Merck & Co., Inc.
MRK
$130.38
$2.812.20%
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 15.78B | 14.63B | 15.96B | 15.04B | 14.49B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 15.78B | 14.63B | 15.96B | 15.04B | 14.49B |
| Cost of Revenue | 3.42B | 3.80B | 4.23B | 3.99B | 3.90B |
| Gross Profit | 12.35B | 10.84B | 11.73B | 11.04B | 10.59B |
| SG&A Expenses | 2.30B | 1.98B | 2.60B | 2.54B | 2.36B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.71B | 14.62B | 10.14B | 19.85B | 10.54B |
| Operating Income | 6.06B | 12.00M | 5.82B | -4.82B | 3.95B |
| Income Before Tax | 5.67B | -2.05B | 5.62B | -5.34B | 3.65B |
| Income Tax Expenses | 903.00M | -820.00M | 870.00M | 637.00M | 825.00M |
| Earnings from Continuing Operations | 4.77B | -1.23B | 4.75B | -5.97B | 2.83B |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -5.00M | 0.00 | -5.00M | -3.00M | -4.00M |
| Net Income | 4.76B | -1.23B | 4.75B | -5.98B | 2.82B |
| EBIT | 6.06B | 12.00M | 5.82B | -4.82B | 3.95B |
| EBITDA | 6.98B | 915.00M | 6.80B | -3.94B | 4.92B |
| EPS Basic | 1.88 | -0.48 | 1.87 | -2.35 | 1.11 |
| Normalized Basic EPS | 1.43 | -0.26 | 1.44 | -1.21 | 0.81 |
| EPS Diluted | 1.87 | -0.48 | 1.86 | -2.35 | 1.11 |
| Normalized Diluted EPS | 1.42 | -0.26 | 1.43 | -1.21 | 0.81 |
| Average Basic Shares Outstanding | 2.53B | 2.53B | 2.54B | 2.54B | 2.54B |
| Average Diluted Shares Outstanding | 2.54B | 2.53B | 2.55B | 2.54B | 2.55B |
| Dividend Per Share | 0.77 | 0.73 | 0.73 | 0.73 | 0.73 |
| Payout Ratio | 40.95% | -151.06% | 39.09% | -31.55% | 65.69% |
